Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 6 items

Development of a Composite Scoring Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (Alliance)

Basch, Ethan , Becker, Claus , Rogak, Lauren , Spears, Patricia ... - ISOQOL - QUALITY OF LIFE RESEARCH - 2019

Abstract - Secondary-not-in-original - Primary - Health Outcomes - Alliance-A091105

A cluster-randomized study of clinician-patient shared vs standard reporting of symptomatic adverse events using PRO-CTCAE nested in a multicenter trial of multimodal therapy for rectal cancer (Alliance N1048 PROSPECT)

Dueck, Amylou C. , Mitchell, S.A. , Rogak, Lauren I. , Ginos, Brenda ... - ISOQOL - Qual Life Res - 2015

Abstract - Secondary - Primary - GI - NCCTG-N1048

Patient-reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in NCCTG (Alliance) N1031 (Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer)

Dueck, Amylou C. , Sideras, Kostandinos , Sloan, Jeff ... - ISOQOL - Quality of Life Research - 2013

Abstract - Secondary - Primary - Breast - NCCTG-N1031

Incorporating Clinicians’ CTCAE Grades as Auxiliary Variables When Imputing Patients’ PRO-CTCAE Scores via Multiple Imputation in Alliance A091105

Mazza, Gina L. , Petersen, Molly M. , Rogak, Lauren J. ... - ISOQOL - Quality of Life Research - 2020

Abstract - Secondary - Primary - Health Outcomes - Alliance-A151925 , Alliance-A091105

Health-related quality of life outcomes for the LEAP Study - Alliance 70305: a lymphedema prevention intervention trial for newly-diagnosed breast cancer patients

Naughton, MJ , Seisler, DK , Sloan, JA , Liu, H , Le-Rademacher, J ... - ISOQOL - Qual Life Res - 2018

Abstract - Secondary - Primary - Health Outcomes - CALGB-70305

Clinically Significant Effect Sizes for Survival and Response Endpoints Using the 1/2 Standard Deviation Rule.

Sloan, J. A. , Novotny, P. J. , Sargent, D. J. , Decker, P. ... - ISOQOL - Qual Life Res - 2010

Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N9741